The potentially explosive power of compounded growth is a matter of simple math. You'll need significant regular investments, a solid growth rate, and time. Multiple people of very limited means have ...

Forbes contributors publish independent expert analyses and insights. Wayne Winegarden covers the economic impacts of regulatory policies The new class of GLP-1 medicines exemplifies both the ...

COLORADO SPRINGS — Maybe you’ve heard of someone taking GLP-1s, or you’ve seen celebrities like Serena Williams talk about taking them for weight loss. Over the past few years, it’s been sold to ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying “regulatory neglect” is allowing for potentially dangerous, ...

Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. The decision to take a brand-name or compounded GLP-1 ...

The surge in demand for GLP-1 medicines has led to a market made up of compounded versions sold online. While compounding pharmacies are essential for patients who can’t medically tolerate ...

"Enjoy the magic of compounding returns. Even modest investments made in one's early 20s are likely to grow to staggering amounts over the course of an investment lifetime." -- John C. Bogle That's ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...

In April, Ohio Attorney General Dave Yost sent letters to 14 medical spas warning them to stop making false or misleading claims about their versions of weight-loss drugs like Ozempic, Wegovy and ...

Empower Pharmacy markets itself as a well-meaning rival to Big Pharma — one that seeks to democratize medicine by making affordable, personalized drugs for patients who need them. As one of an ...

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S.